VERTEX PHARMACEUTICALS INCORPORATED

Lobbying client · Massachusetts · filed 2025 to 2026

biopharmaceutical company

$200,000 Reported spend

6 Filings counted

1 Firms hired

2 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (56149), not by name.

Firms hired 1

CROSSROADS STRATEGIES, LLC $200,000 6 filings

Bills named in these filings 2

S 475
Alternatives to PAIN Act

6 filings
HR 1227
Alternatives to PAIN Act

5 filings

Reported by year 2 years

2026 $80,000 2 filings
2025 $120,000 4 filings

Issues lobbied 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

HOUSE OF REPRESENTATIVES 6
SENATE 6
Health & Human Services, Dept of (HHS) 5

Recent filings 6 total

Q2

CROSSROADS STRATEGIES, LLC

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $50,000 income · posted Jul 17, 2026

View → Q1

CROSSROADS STRATEGIES, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $30,000 income · posted Apr 20, 2026

View → Q4

CROSSROADS STRATEGIES, LLC

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $30,000 income · posted Jan 19, 2026

View → Q3

CROSSROADS STRATEGIES, LLC

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $30,000 income · posted Oct 19, 2025

View → Q2

CROSSROADS STRATEGIES, LLC

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $30,000 income · posted Jul 19, 2025

View → Q1

CROSSROADS STRATEGIES, LLC

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $30,000 income · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.